Laboratory confirmation of dengue-3 virus outbreak in Mandera, Northern Kenya, 2011  by Ofula, V. et al.
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demic and outbreak situations and avoids economical loses in the
country
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opulation and may cause important outbreaks. Surveillance and
ontrolmethods shouldbeused to retain the spreadof this serotype
nd to consequently avoid a likely increase in hemorrhagic clinical
anifestations due to the recent circulation of other serotypes in
he municipality.
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aboratory conﬁrmation of dengue-3 virus outbreak in Man-
era, Northern Kenya, 2011
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Background:Dengue amosquito-borne viral infection is caused
y four dengue virus serotypes (DENV-1, DENV-2, DENV-3, and
ENV-4) that are antigenically distinct. All DENVs are transmitted
o humans through the bite of infectedmosquitoes, primarilyAedes
egyptiandAedes albopictusspecies. In September 2011, reports
ere received from Mandera District Disease surveillance ofﬁce
f an unusually high number of patients visiting health facilities,
ith high fever, severe arthralgia and myalgia with some report-
ng gingival and nasal hemorrhages. Most patients were negative
or malaria, though they were treated with anti-malarial medicine
ith no improvement. An investigation was conducted to conﬁrm
nd determine the cause of the illness.
Methods: Blood Samples from sick patients were collected and
ransported to the Arbovirus/Viral Hemorrhagic Fever (VHF) labo-
atory for arboviruses testing using enzyme linked immunosorbent
ssay-IgM (IgM-ELISA), real time reverse transcriptase polymerase
hain reaction (rRT-PCR) and conventional reverse transcrip-
ase polymerase chain reaction (RT-PCR).Virus isolation was also
ttempted in Vero cell lines
Results: A total of 43 blood samples were collected and tested.
total of 11 samples (25.6%) were positive for Dengue virus by
gM ELISA, 29 (67.4%) were positive for Dengue virus by real time
CR and 26/43 (60.5%) were positive were for Dengue-3 virus by
onventional RT-PCR. Virus isolation was unsuccessful despite two
assage attempts.
Conclusion: The outbreak that occurred in Mandera, north-
rn Kenya was caused by Dengue virus. After molecular diagnosis,
engue virus serotype 3 was the cause of the acute febrile illness.
he disease was most likely imported from neighboring Somalia
hich had an ongoing outbreak since June 2011. This calls for the
eed for strengthened surveillance with strong laboratory capacity
n the region to detect and respond to any potential outbreaks in
uture.
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Countermeasures for the control of African Swine Fever in
Georgia
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Background: African Swine Fever Virus (ASFV) is the cause an
acute, highly contagious, infectious disease in domestic pigs that is
usually lethal to the animal. There is no vaccine for the virus and
the potential distribution of the infection is global. Therefore, most
countries free of the disease take signiﬁcant measures to prevent
the entry of the virus. Georgia reported ASFV to the World Organi-
zation forAnimalHealth (OIE) in 2007 after ﬁnal conﬁrmationby an
OIE reference laboratory. Sequence analysis of the Georgian ASFV
isolate revealed a close relationship to viral strains from Southeast
Africa (Mozambique, Madagascar and Zambia). The epidemiolog-
ical course of the disease was unclear. Retrospectively, the ﬁrst
clinical cases attributed to ASF were seen in the port of Poti sit-
uated in Western Georgia on the Black Sea (May 2007). The virus
may have been introduced by ships carrying contaminated meat or
meatproducts. Countermeasures for the control ofASFwere carried
out at the LMA with a joint collaboration with PIADC.
Methods:Samples fromswine thatwerecollectedand included:
serum, blood, lymph nodes, spleen, tonsils, lung, liver, and kid-
ney. Samples were collected throughout Georgia. All samples were
tested by ELISA and positive samples were conﬁrmed by PCR. GIS
techniques were also used to show the distribution of the disease
by regions.
Results: In total, 2310 samples were tested since 2007-2011.
A total of 239 positive samples were detected since 2007. All the
activities were executed in close collaboration and coordination
with US researchers at the Plum Island Animal Disease Center. Pos-
itive samples were transferred there for further investigation.
Conclusion: Active surveillance of ASFV in Georgia limits epi-
